1 / 43

Ventilatory support in special situations

Ventilatory support in special situations. Dr.Balamugesh.T, MD, DM Dept. of Pulmonary Medicine, CMC, Vellore. And the Lord God formed man of the dust of the ground, and breathed into his nostrils and breath of life, and man become a living soul. Genesis 2:7. ARDS COPD Bronchial asthma

betty_james
Download Presentation

Ventilatory support in special situations

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Ventilatory supportin special situations Dr.Balamugesh.T, MD, DM Dept. of Pulmonary Medicine, CMC, Vellore.

  2. And the Lord God formed man of the dust of the ground, and breathed into his nostrils and breath of life, and man become a living soul. Genesis 2:7

  3. ARDS • COPD • Bronchial asthma • Bronchopleural fistula

  4. ARDS • Acute onset • Hypoxia- PaO2/FiO2<200 • Bilateral infiltrates on CXR • Absence of left atrial hypertension Mortality - 26% to 74%

  5. Ventilation Induced Lung Injury • Volutrauma – over distention of alveoli • Barotrauma – high inflation pressures • Atelectrauma - repetitive opening and closing of alveoli • Biotrauma - up-regulated cytokine release • Oxygen toxicity

  6. Ventilation in ARDS • Which mode? • How much FiO2? • How much PEEP? • How much VT? • Target? • What if refractory ARDS?

  7. Which mode? • Volume assist/control commonly used • Plateau-pressure goal ≤30 cm of water ARDS Clinical Trials Network

  8. How much FiO2? • Least FiO2 to achieve Oxygenation goal • PaO2 55–80 mm Hg • SpO2 88–95% • FiO2 > 60% risk of oxygen toxicity.

  9. How much Tidal volume? ARDS Network Mortality • Low tidal volume -31% (6 mL/kg predicted body weight) • Conventional tidal volume -40% (12 mL/kg)

  10. PEEP • Improves oxygenation by providing movement of fluid from the alveolar to the interstitial space, • Prevent cyclical alveolar collapse • Recruitment of small airways collapsed alveoli, • Increase in FRC

  11. Open Lung Ventilation (OLV) • Objective - maintenance of adequate oxygenation and avoidance of cyclic opening and closing of alveolar units by selecting a level of PEEP that allows the majority of units to remain inflated during tidal ventilation • Trade off - Hypercapnia

  12. PEEP…. • The lower inflection point on the static pressure–volume curve represents alveolar opening (or “recruitment”). • “optimal PEEP” - The pressure just above this point, is best for alveolar recruitment • usually 10 to 18 mmHg

  13. optimal PEEP J J Cordingley, Thorax 2002;57

  14. How much PEEP? • Low PEEP(8.3±3.2 cm of water) • High PEEP (13.2±3.5 cm) No difference in outcomes if VT- 6ml/kg and Plat. Pressure <30cm N Engl J Med 2004;351

  15. Permissive hypercapia – • usually well tolerated • Consequences • myocardial depression, • Pulmonary hypertension • Raised ICT • Increase RR • Judicious bicarbonate • Tracheal gas insufflation – to wash out dead space CO2

  16. Protective lung ventilation protocol from the ARDSNet study • Initial tidal volume – 6ml/kg • Plat. Pressure <30cm H20 • Oxygenation goal PaO2 = 55 - 80 mmHg or pulse oximetry oxygen saturation 88–95% • I:E ratio 1:1–1:3 • Goal arterial pH = 7.30–7.40  • If pH < 7.30, increase respiratory rate up to 35 breaths/min  • If pH < 7.30 and respiratory rate = 35, consider starting intravenous bicarbonate

  17. Refractory hypoxia • 1. Neuromuscular blocking agents (if not already in use) • 2. Prone position ventilation • 3. Recruitment maneuvers • 4. Inverse ratio ventilation, • 5. Miscellaneous – • nitric oxide, • high-frequency ventilation, • extracorporeal membrane oxygenation, or • partial liquid ventilation

  18. Prone position ventilation • Improve oxygenation • Better FRC • Recruitment of dorsal lung • Better clearance of secretion • Better ventilation-perfusion matching • Potential problems • facial oedema, eye damage • dislodgment of endotracheal tubes and intravascular catheters • Difficulty in resuscitation No differences in clinical outcome

  19. Recruitment manoeuvres • Sigh function in ventilators • By ambu bag • Sustained inflation or CPAP of 30-45 cm H20 for 20-120 sec.

  20. Inverse ratio ventilation • Prolongation of the inspiratory time as a method of recruitment • Pressure control ventilation to increase the I:E ratio to 1:1 or 2:1 • hyperinflation and the generation of intrinsic PEEP

  21. Obstructive lung disease • COPD • Asthma

  22. Indications for NIV for AE-COPD GOLD 2005

  23. Exclusion criteria GOLD 2005

  24. Indications forInvasive Mechanical Ventilation GOLD 2005

  25. Think twice • Reversibility of the precipitating event, • Patient’s/relative’s wishes, and • Availability of intensive care facilities • Failure to wean Mortality among COPD patients with respiratory failure is no greater than mortality among patients ventilated for non-COPD causes GOLD 2005

  26. Post-Intubation hypotension • Reduced venous return secondary to positive intrathoracic pressure due to bagging • Direct vasodilation and reduced sympathetic tone induced by sedative agents

  27. Mechanical ventilation • Avoid overcorrection of respiratory acidosis and life threatening alkalosis. • Prolonged expiratory time. I:E – 1:2.5 to 1:3. • Low Respiratory Rate- 10-14/mt. • Limited tidal volume

  28. PEEP • PEEPe beneficial • Reduce gas trapping by stenting open the airways • Reduce the work to trigger inspiratory flow • As PEEPe is applied, tidal volume will increase without an increase in airway pressure until PEEPe exceeds PEEPi

  29. Allow early extubation Prevent post extubation respiratory failure Post extubation NIV

  30. Asthma

  31. NIV in asthma • Few trials • Trial of NIV over 1–2 hours in an ICU if there are no contraindications

  32. NIV in acute bronchial asthma • FEV1<40%, PaCO2 <40mm Hg • Conventional medical management Vs BiPAP 15/5 for 3 hours Chest. 2003;123

  33. NIV in asthma…. • 80% NIV group increased FEV1 by >50% as compared to baseline, vs 20% of control patients (p < 0.004) • alleviate the attack faster, and • significantly reduce the need for hospitalization.

  34. Endotracheal intubation • Absolute indications • Cardiopulmonary arrest and • Deteriorating consciousness • Relative • Progressive deterioration, hypercapnia with increasing distress or physical exhaustion

  35. Intubation performed/supervised by experienced anaesthetists or intensivists • Use larger endotracheal tube

  36. • FiO2= 1.0 (initially) • Long expiratory time (I:E ratio >1:2) • Low tidal volume 5–7 ml/kg • Low ventilator rate (8–10 breaths/min) • Set inspiratory pressure 30–35 cm H2O on pressure control ventilation or limit peak inspiratory pressure to <40 cm H2O • Minimal PEEP <5 cm H2O

  37. Aerosol delivery Metered dose inhaler (MDI) system • Spacer or holding chamber • Location in inspiratory limb rather than Y piece • No humidification (briefly discontinue) • Actuate during lung inflation • Large endotracheal tube internal diameter • Prolonged inspiratory time

  38. Jet nebuliser system • Mount nebuliser in inspiratory limb • Consider continuous nebulisation • Increase inspiratory time and decrease respiratory rate • Use a spacer • Stop humidification • Delivery may be improved by inspiratory triggering

  39. Ventilator strategies in Bronchopleural fistula

  40. Air escaping through the BPF • delays healing of the fistulous track • significant loss of tidal volume, jeopardizing the minute ventilation and oxygenation

  41. Measures to reduce air-leak • Limit the amount of PEEP • Limit the effective tidal volume, • Shorten inspiratory time, • Reduce respiratory rate. • Use of double-lumen intubation with differential lung ventilation,

  42. Chest tube • To add positive intrapleural pressure during the expiratory phase to maintain PEEP • Occlusion during the inspiratory phase to decrease BPF flow

  43. High-frequency ventilation (HFV) • Useful in patients with normal lung parenchyma and proximal BPF • Limited value in patients with distal disease and parenchymal disease.

More Related